자연폐경 한국여성에서 종양괴사인자 유전자 다형성과 호르몬치료 후 골밀도 변화 사이의 연관성에 관한 연구

키워드

참고문헌 (40)

1. NIH Consensus development panel, "Osteoporosis prevention, diagnosis, and therapy", JAMA, 285, pp.785~795 (2001)
2. Krall EA, "Heritable and life style determinants of bone mineral density", J Bone Miner Res, 8, pp.1~9 (1993)
3. Gennari L, "Genetics of osteoporosis: role of steroid hormone receptor gene polymorphisms", J Steroid Biochem Mol Biol, 81, pp.1~24 (2002)
4. MacGregor A, "Genetic factors and osteoporotic fractures in elderly people. Twin data support genetic contribution to risk of fracture", BMJ, 320, pp.1669~ (2000)
5. Morrison NA, "Prediction of bone density from vitamin D receptor alleles", Nature, 367, pp.284~287 (1994)
6. Kobayashi S, "Association of bone mineral density with polymorphism of the estrogen receptor gene", J Bone Miner Res, 11, pp.306~311 (1996)
7. Grant SF, "Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene", Nat Genet, 14, pp.203~205 (1996)
8. Liu YZ, "Molecular studies of identification of genes for osteoporosis: the 2002 update", J Endocrinol, 177, pp.147~196 (2003)
9. Kim JG, "Association of vitamin D receptorand estrogen receptor gene polymorphisms with bone mass in postmenopausal Korean women", Menopause, 8, pp.222~228 (2001)
10. 김정구, "한국 폐경여성에서 비타민 D 수용체 유전자 다형성과 골밀도의 연관성", Obstetrics & Gynecology Science, 45(11), pp.15~15 (2002), 대한산부인과학회
11. 김정구, "한국 폐경여성에서 비타민 D 수용체 유전자내 Poly (A) 다형성과 골밀도의 연관성", Obstetrics & Gynecology Science, 46(4), pp.16~16 (2003), 대한산부인과학회
12. Kim JG, "The relationship among serum insulin-like growth factor-I, insulin-like growth factor-I gene polymorphism and bone mineral density in postmenopausal women in Korea", Am J Obstet Gynecol, 186, pp.345~350 (2002)
13. Kim JG, "Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women", Menopause, 14, pp.913~918 (2007)
14. Pines A, "IMS updated recommendations on postmenopausal hormone therapy", Climacteric, 10, pp.181~194 (2007)
15. Writing Group for the Women's Health Initiative Investigators, "Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial", JAMA, 288, pp.321~333 (2002)
16. The Women's Health Initiative Steering Committee, "Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial", JAMA, 291, pp.1701~1712 (2004)
17. Hassager C, "Nonresponders to hormone replacement therapy for the prevention of postmenopausal bone loss: Do they exist", Osteoporosis Int, 4, pp.36~41 (1994)
18. Kurabayashi T, "Association of vitamin D and estrogen receptor gene polymorphism with the effect of hormone replacement therapy on bone mineral density in Japanese women", Am J Obstet Gynecol, 180, pp.1115~1120 (1999)
19. Deng HW, "Change of bone mass in postmenopausal Caucasian women with and without hormone re placement therapy is associated with vitamin D receptor and estrogen receptor genotypes", Hum Genet, 103, pp.576~585 (1998)
20. Yamada Y, "Association of transforming growth factor beta1 genotype with therapeutic response to active vitamin D for postmenopausal osteoporosis", J Bone Miner Res, 15, pp.415~420 (2000)
21. 김정구, "한국 폐경여성에서 비타민 D 수용체 유전자 다형성과 호르몬대체요법이 골밀도에 미치는 영향과의 연관성", Obstetrics & Gynecology Science, 46(5), pp.15~15 (2003), 대한산부인과학회
22. Kim JG, "The Calcitonin Gene (CA) Polymorphism, Bone Mineral Density, and Bone responsiveness to Hormone Treatment in Postmenopausal Korean Women", Korean J Osteoporosis, 1, pp.130~139 (2003)
23. Kim JH, "The Change of Bone Mineral Density afterHormone Replacement Therapyaccording to CA Repaet Polymorphism inInsulin-Like Growth factor (IGF)-I Gene", JKSM, 1, pp.217~225 (2003)
24. Weitzmann MN, "Estrogen deficiency and bone loss: an inflammatory tale", J Clin Invest, 116, pp.1186~1194 (2006)
25. Roggia C, "Role of TNF-α producing T-cells in bone loss induced by estrogen deficiency", Minerva Med, 95, pp.125~132 (2004)
26. Roggia C, "Up-regulation of TNFproducing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo", Proc Natl Acad Sci USA, 98, pp.13960~13965 (2001)
27. Ota N, "Association of a single nucleotide variant in the human tumour necrosis factor alpha promoter region with decreased bone mineral density", Ann Hum Biol, 29, pp.550~558 (2002)
28. Furuta I, "Bone mineral density of the lumbar spine is associated with TNF gene polymorphisms in early postmenopausal Japanese women", Calcif Tissue Int, 74, pp.509~515 (2004)
29. Lee N, "Tumor necrosis factor-alpha haplotype is strongly ssociated with bone mineral density in patients with Crohn's disease", J Gastroenterol Hepatol, 22, pp.913~919 (2007)
30. Fontova R, "Bone mineral mass is associated with interleukin 1 receptor autoantigen and TNF-alpha gene polymorphisms in postmenopausal Mediterranean women", J Endocrinol Invest, 25, pp.684~690 (2002)
31. Wennberg P, "TNF-alpha gene polymorphism and plasma TNF-alpha levels are related to lumbar spine bone area in healthy female Caucasian adolescents", Eur J Endocrinol, 146, pp.629~634 (2002)
32. Chen HY, "Tumor necrosis factor alpha, CYP 17, urokinase, and interleukin 10 gene polymorphisms in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporosis", Eur J Obstet Gynecol Reprod Biol, 122, pp.73~78 (2005)
33. Xiao P, "Association tests of interleukin-6 (IL-6) and type II tumor necrosis factor receptor (TNFR2) genes with bone mineral density in Caucasians using a re-sampling approach", Hum Genet, 117, pp.340~348 (2005)
34. Santos JL, "Adiposity and bone mineral density of Chilean elderly women in relation to toll-like receptor 4 gene polymorphisms", Ann Hum Biol, 33, pp.585~592 (2006)
35. Pacifici R, "Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells", Proc Natl Acad Sci USA, 88, pp.5134~5138 (1991)
36. Vural P, "Effects of hormone replacement therapy on plasma pro-inflammatory and anti-inflammatory cytokines and some bone turnover markers in postmenopausal women", Pharmacol Res, 54, pp.298~302 (2006)
37. Han KO, "Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women", J Clin Endocrinol Metab, 82, pp.991~995 (1997)
38. Chun S, "The Relationship between Tumor Necrosis Factor (TNF)-TNF Receptor (TNFR) Gene Polymorphisms and the Production of TNF and Soluble TNFR (sTNFR) by Whole Blood Cells in Korean Postmenopausal Women", JKSM, 14, pp.227~237 (2008)
39. Kim H, "The Relationship between Changes in the Production of Tumor Necrosis Factor (TNF)-α, TNF-β, Soluble TNF Receptor 1 (sTNFR1), sTNFR2 by Whole Blood Cells and Changes in Bone Mineral Density after Estrogen-progestogen Therapy in Postmenopausal Women", JKSM, 14, pp.139~148 (2008)
40. The Korean Society of Bone Metabolism, "osteoporosi", pp.19~26 (2006), Hanmi Book

관련 논문AI추천